BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Odyssey Group Approved to Start Human Trial to Treat Concussion

The Company’s Clinical Trial Protocol was approved by the Alfred Ethics Committee and allows for the immediate start of the human trial. “We a...

September 08, 2021 | News

Study Confirms Viraleze Provides Protection Against SARS-CoV-2

The findings, published in the peer-reviewed journal Viruses, in a special issue titled Medical Interventions for Treatment and Prevention of SAR...

August 24, 2021 | News

BioAgilytix to Purchase Australia-based 360biolabs®

BioAgilytix Labs, LLC (BioAgilytix), a leading global contract research laboratory focused on supporting its pharmaceutical and biotech partners in all sta...

August 17, 2021 | News

Strengthening Australia’s regenerative medicine value chain

The Australian biotech sector is actively considering how it can support greater access to ground-breaking therapies for Australians, as RM challenges the ...

August 13, 2021 | News

Diabetes treatment lowers PromarkerD risk score for diabetic kidney disease

In a study presented at the Australasian Diabetes Congress today, researchers used PromarkerD, the world's first predictive diagnostic test for diabetic ki...

August 13, 2021 | News

Peninsula Health Forges New Model for Healthcare Delivery with Citrix® and Logicalis

When COVID-19 began sweeping the globe, Australia was quick to lockdown. And Peninsula Health was equally quick to respond. With the help of ...

August 12, 2021 | News

Ascensia Presents First Ever Data At Australasian Diabetes Conference 2021

Ascensia Diabetes Care, a global diabetes company has today disclosed data at the virtual Australasian Diabetes Conference (ADC) 2021, which takes place&nb...

August 11, 2021 | News

Australian Therapeutic Goods Administration Grants Provisional Registration for Moderna’s COVID-19 Vaccine

Delivery to begin in the second half of September -Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics...

August 11, 2021 | News

Australia Unite to Urgently Tackle 'Symptom Hesitancy' and Testing 'Rollercoaster

Growing concern among Australian cancer organisations that ongoing COVID-19 lockdowns, and delays in routine procedures are causing cancer 'symptom ...

August 10, 2021 | News

Pharmaxis Cancer Drug Decreases Tumour Burden in Pre Clinical Liver Cancer Model

Clinical stage drug development company Pharmaxis Ltd (ASX: PXS) today announced the first public presentation of data from a preclinical study of PXS-5505...

August 06, 2021 | News

$3.3 million to support Australians living with a rare disease

The Morrison Government is providing $3.3 million to support the approximate two million Australians living with a rare disease, providing them with suppor...

August 02, 2021 | News

Lupin Acquires Southern Cross Pharma in Australia

Incorporated in Melbourne, Australia, SCP is engaged in developing, registering, and distributing generic products. As a part of the transaction, Generic H...

July 30, 2021 | News

Clarity commences theranostic prostate cancer trial

Clarity's Executive Chairman, Dr Alan Taylor, commented, "The prostate cancer market is a key focus for Clarity and we are very pleased to commence th...

July 29, 2021 | News

VIRALEZE SPL7013 virucidal (>99.99%) against Delta variant

New antiviral testing demonstrates SPL7013, the antiviral agent in VIRALEZE™ nasal spray, has potent virucidal activity against the globally signif...

July 28, 2021 | News

Stay Connected